GraniteShares 2x Long COIN Daily ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $5.34 (market cap $510.01M), while Roivant Sciences Ltd. Common Shares trades at $34.76 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 48.5× GraniteShares 2x Long COIN Daily ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long COIN Daily ETF for 15 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| CONL | ROIV | |
|---|---|---|
Market Cap | $510.01M | $24.72B |
Volume | 21,041,836 | 6,279,442 |
Sector | Leveraged / Inverse | Health |
52-Week High | $48.58 | $41.81 |
52-Week Low | $3.93 | $16.04 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | — | $20.99B |
Signals from Pluang's Aura AI — not financial advice
CONL (GraniteShares 2x Long COIN Daily ETF) trades at $4.91, down 6.12% with bearish technical signals from moving averages. The ETF tracks Coinbase stock with 2x daily leverage, amplifying volatility. Recent news highlights significant price gaps and performance swings, with one article noting an 85% decline when Coinbase fell 50%. Technical indicators show oversold conditions with RSI readings below 30, suggesting potential near-term bounce.
Outlook remains highly speculative due to leveraged structure and dependency on Coinbase performance. Investment opportunity exists for tactical traders betting on Coinbase recovery, but risks include amplified losses, daily rebalancing decay, and crypto market volatility. Conservative investors should avoid due to extreme risk profile.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →